NCT02552225View on ClinicalTrials.gov

Treatment of Chronic Laryngitis With Amitriptyline

PHASE2/PHASE3TerminatedINTERVENTIONAL
Enrollment

6

Participants

Timeline

Start Date

April 30, 2016

Primary Completion Date

January 15, 2021

Study Completion Date

January 15, 2021

Conditions
Laryngeal Diseases
Interventions
DRUG

Amitriptyline

Subjects in this arm will receive pills composed of amitriptyline and Avicel (cellulose filler)

OTHER

Placebo

Subjects in this arm will receive pills composed only of Avicel (cellulose filler)

Trial Locations (1)

02118

Boston Medical Center, Boston

Sponsors
All Listed Sponsors
lead

Boston Medical Center

OTHER